Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly kno...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

Bobinato Feb. 18 at 3:39 PM

$NRXS no volume but by god it's beautiful

0 · Reply

trading_momentum_x Feb. 15 at 4:38 AM

$NRXS has been a slow and steady gainer and its cup and handle justifies its movement. Could easily see 6$ or more here

0 · Reply

trading_momentum_x Feb. 15 at 3:29 AM

$NRXS on watch still for its cup and handle play. We’ve seen a breakout above the neckline and a pullback and now another leg up. The cup and handle Vpa gives this an estimated target near 6$, near its last major breakout resistance

0 · Reply

allisonmarie Feb. 12 at 3:03 PM

$NRXS Big Short Squeeze beginning. Up 10% now. Need volume for a huge pop...

0 · Reply

allisonmarie Feb. 12 at 2:52 PM

$NRXS Short squeeze now..... Once this breaks $5.00, off to the races.

0 · Reply

Tennis_4567 Feb. 10 at 9:00 PM

$NRXS

0 · Reply

allisonmarie Feb. 10 at 8:02 PM

$NRXS is set up for an explosive short squeeze if we can get volume behind it......

0 · Reply

allisonmarie Feb. 10 at 7:42 PM

Short squeeze setting up on $NRXS

0 · Reply

VolumeCore Feb. 9 at 2:07 PM

$NRXS Pharmacy or healthcare IT; operates in a complex, regulated reimbursement environment.

0 · Reply

BillionerOfKing Feb. 6 at 10:00 AM

$NRXS Current Stock Price: $4.35

0 · Reply

NeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 7:00 AM EST - 3 months ago

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Aug 12, 2025, 12:29 PM EDT - 6 months ago

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript

Jun 17, 2025, 8:00 AM EDT - 8 months ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

May 22, 2025, 1:03 PM EDT - 9 months ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 9 months ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 1:58 PM EDT - 10 months ago

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 8:15 AM EDT - 10 months ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 10 months ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Mar 20, 2025, 4:18 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Jan 21, 2025, 1:45 PM EST - 1 year ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Nov 15, 2024, 2:04 PM EST - 1 year ago

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 11, 2024, 5:44 AM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jun 7, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 1:34 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

May 22, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 1 year ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 6:45 PM EDT - 2 years ago

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

Apr 9, 2024, 4:05 PM EDT - 2 years ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 1, 2024, 4:15 PM EDT - 2 years ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 2 years ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 2 years ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 2 years ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 13, 2023, 9:00 AM EDT - 2 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Strength of its Board of Directors

Aug 22, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 17, 2023, 9:02 AM EDT - 2 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

Bobinato Feb. 18 at 3:39 PM

$NRXS no volume but by god it's beautiful

0 · Reply

trading_momentum_x Feb. 15 at 4:38 AM

$NRXS has been a slow and steady gainer and its cup and handle justifies its movement. Could easily see 6$ or more here

0 · Reply

trading_momentum_x Feb. 15 at 3:29 AM

0 · Reply

allisonmarie Feb. 12 at 3:03 PM

$NRXS Big Short Squeeze beginning. Up 10% now. Need volume for a huge pop...

0 · Reply

allisonmarie Feb. 12 at 2:52 PM

$NRXS Short squeeze now..... Once this breaks $5.00, off to the races.

0 · Reply

Tennis_4567 Feb. 10 at 9:00 PM

$NRXS

0 · Reply

allisonmarie Feb. 10 at 8:02 PM

$NRXS is set up for an explosive short squeeze if we can get volume behind it......

0 · Reply

allisonmarie Feb. 10 at 7:42 PM

Short squeeze setting up on $NRXS

0 · Reply

VolumeCore Feb. 9 at 2:07 PM

$NRXS Pharmacy or healthcare IT; operates in a complex, regulated reimbursement environment.

0 · Reply

BillionerOfKing Feb. 6 at 10:00 AM

$NRXS Current Stock Price: $4.35

0 · Reply

biggercapital Feb. 4 at 12:37 AM

Our $NRXS filing https://www.sec.gov/Archives/edgar/data/1288478/000092189526000208/xslSCHEDULE_13G_X01/primary_doc.xml

1 · Reply

AshenBlade Feb. 1 at 10:43 PM

$NRXS Liquidity pressure raises questions about how long the company can operate without additional financing..

1 · Reply

AshenBlade Feb. 1 at 10:42 PM

$NRXS Gross margins have compressed due in part to discounting through patient assistance programs and inventory issues.

0 · Reply

AshenBlade Feb. 1 at 10:40 PM

$NRXS

0 · Reply

Tennis_4567 Jan. 22 at 12:58 PM

$NRXS There was some FUD going on this fall around whether or not the CPT-1 code granted this year would actually result in insurance coverage. We can officially put that to bed

0 · Reply

Tennis_4567 Jan. 22 at 12:57 PM

$NRXS

0 · Reply

trading_momentum_x Jan. 22 at 3:08 AM

$NRXS bounce off 21dema. Cup and handle still valid for now, position is back to neutral. Maintaining a 7$ PT for now

0 · Reply